BaroFold Grants Protein Technology Research License to Genentech.BOULDER Boulder, city, United States Boulder, city (1990 pop. 83,312), seat of Boulder co., N central Colo.; inc. 1871. A Rocky Mountain resort and a suburb of Denver, it is the seat of the Univ. of Colorado (1876). , Colo. -- BaroFold, Inc. announced today the granting of a research license to Genentech, Inc. (NYSE NYSE See: New York Stock Exchange :DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. ) for BaroFold's proprietary PreEMT(TM) high pressure technology for solubilizing, disaggregating and refolding proteins under a previously executed service and license agreement. The license agreement enables Genentech to utilize BaroFold's patented technology and instrumentation for research, and grants Genentech an option to trigger a commercial license. Up-front payment, milestones and other financial terms were not disclosed. Genentech joins several other biotechnology firms and pharmaceutical corporations who have collaborated with BaroFold to refold Re`fold´ v. t. 1. To fold again. and produce proteins. "We are pleased to be working with Genentech, a leader and pioneer in the field of therapeutic proteins," said Lyndal Hesterberg, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of BaroFold Inc. "Our team has now delivered useful quantities of over 80 challenging proteins through its collaborations with academics and biologics industry scientists. We hope to support future development of important therapeutic biologics programs at Genentech." About BaroFold BaroFold's patented PreEMT(TM) technology has the potential to provide safer follow-on and proprietary protein therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. at lower cost than traditional biologicals. BaroFold technology enables production of challenging proteins at research or commercial scale thus enabling research and discovery leading to both protein and small molecule therapeutics. The Company leverages its technology through partnerships with research facilities, major biotechnology and pharmaceutical companies. For additional information about the company, please visit http://www.barofold.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion